e-learning
resources
Barcelona 2010
Monday, 20.09.2010
New mechanisms in lung development, acute and chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2010 Abstract: Influence of mutations and COPD clinical features on
SERPINA1
phenotypic expression
D. Serapinas, R. Sakalauskas (Lithuania)
Source:
Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Session:
New mechanisms in lung development, acute and chronic lung diseases
Session type:
E-Communication Session
Number:
2203
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Serapinas, R. Sakalauskas (Lithuania). LSC 2010 Abstract: Influence of mutations and COPD clinical features on
SERPINA1
phenotypic expression. Eur Respir J 2010; 36: Suppl. 54, 2203
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
LSC 2010 Abstract: Functional variant of the
ANXA11
gene: True marker of protection and candidate disease modifier in sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
LSC 2010 Abstract: Possible effect of
GSTM1
and
GSTT1
polymorphisms on the risk for development of COPD and total antioxidant plasma capacity
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
LSC 2010 Abstract: Perforin expression in COPD patients with microsatellite DNA instability
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
LSC 2010 Abstract: The influence of genetic background in a mouse model of chemical-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
"Loss of function" variants of the
P2RX7
gene in Czech patients with sarcoidosis: A genetic association study
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
Pharmacogenetic and clinicopathological markers of BA-COPD (overlap syndrome)
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Single nucleotide polymorphism and asthma: A study on the genetic basis of asthma
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Identification of clinical phenotypes in patients with and without COPD using cluster analysis
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
LSC 2010 Abstract: TNFα promoter polymorphism is associated with increased local production and enhanced downstream inflammation in COPD
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Impact of the genetic variation of GLCCI1 on clinical features of asthmatic patinets
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Clinical COPD phenotypes identified by cluster analysis: validation with mortality
Source: Eur Respir J 2012; 40: 495-496
Year: 2012
Imbalances in TNFα in patients with a TNFα polymorphism and a COPD phenotype
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
LSC Abstract – Identification of distinct biological phenotypes of ARDS by cluster analysis and association with mortality
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Investigating tensin1 expression and the presence of SNP identified in GWAS in COPD
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Therapy of COPD based on clinical phenotypes
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
SNPs in SPINK5 gene region are associated with asthma severity: Preliminary results from the gene environment interactions in respiratory diseases (GEIRD) study
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Definition and characterization of an inflammatory phenotype in patients with COPD - results from the COSYCONET study
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept